Volume 12, Number 1—January 2006
Pandemic Influenza Threat and Preparedness1
- World Health Organization. Confirmed human cases of avian influenza A(H5N1). 2005 [cited 2005 Oct 31]. Available from http://www.who.int/csr/disease/avian_influenza/country/en/
- World Health Organization. Avian influenza: assessing the pandemic threat. 2005 [cited 2005 Oct 31]. Available from http://www.who.int/csr/disease/influenza/WHO_CDS_2005_29/en/index.html
- Specter M. Nature's bioterrorist. New Yorker. 2005;50–61.
- Webby RJ, Webster RG. Are we ready for pandemic influenza? Science. 2003;302:1519–22.
- Monto AS. The threat of and an avian influenza pandemic. N Engl J Med. 2005;352:323–5.
- Stohr K. Avian influenza and pandemics: research needs and opportunities. N Engl J Med. 2005;352:405–7.
- Institute of Medicine. The threat of pandemic influenza: are we ready? 2004 Nov [cited 2005 Oct 21]. Available from http://www.iom.edu/report.asp?id=23639
- Couch RB. An overview of serum antibody responses to influenza virus antigens. Dev Biol (Basel). 2003;115:25–30.
- Reid AH, Taubenberger JK, Fanning TG. The 1918 Spanish influenza: integrating history and biology. Microbes Infect. 2003;3:81–7.
- World Organization for Animal Health. Update on avian influenza in animals (type 5). 2005 Oct 28 [cited 2005 Oct 31]. Available from http://www.oie.int/downld/AVIAN%20INFLUENZA/A_AI-Asia.htm
- Food and Agriculture Organization. AIDE News: AI Bulletin. Update on the avian influenza situation (as of 1/9/2005). Issue no. 33. [cited 2005 Oct 31]. Available from http://www.fao.org/ag/againfo/subjects/documents/ai/AVIbull033.pdf
- Chen H, Smith GJ, Zhang SY, Qin K, Wang J, Li KS, Avian flu: H5N1 virus outbreak in migratory water fowl. Nature. 2005;436:191–2.
- Liu J, Xiao H, Lei F, Zhu Q, Qin K, Zhang X, Highly pathogenic H5N1 influenza virus infection in migratory birds. Science. 2005;309:1206.
- Kuiken T, Rimmelzwaan G, van Riel D, van Amerongen G, Baars M, Fouchier R, Avian influenza in cats. Science. 2004;306:241.
- Keawcharoen J, Oraveerakul K, Kuiken T, Fouchier RA, Amonsin A, Payungporn S, Avian influenza in tigers and leopards. Emerg Infect Dis. 2004;10:2189–91.
- World Health Organization. Avian influenza: H5N1 detected in pigs in China. WHO Communicable Disease Surveillance and Response. 2004 Aug 20 [cited 2005 Oct 21]. Available from http://www.who.int/csr/don/2004_08_20/en/
- Olsen SJ, Ungchusak K, Sovann L, Uyeki TM, Dowell SF, Cox NJ, Family clustering of avian influenza A (H5N1). Emerg Infect Dis. 2005;11:1799–801.
- Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthhavathana P, Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med. 2005;352:333–40.
- World Health Organization. Avian influenza: situation updates. 2005 [cited 2005 Oct 21]. Available from http://www.who.int/csr/disease/avian_influenza/updates/en/
- Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Human infection with influenza H9N2. Lancet. 1999;354:916–7.
- Choi YK, Ozaki H, Webby RJ, Webster RG, Peiris JS, Poon L, Continuing evolution of H9N2 influenza viruses in southeastern China. J Virol. 2004;78:8609–14.
- Centers for Disease Control and Prevention. Avian influenza infection in humans. 2005 Oct 17 [cited 2005 Oct 21]. Available from http://www.cdc.gov/flu/avian/gen-info/avian-flu-humans.htm
- Guo Y, Li J, Cheng X. Discovery of men infected by avian influenza A H9N2 virus. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 1999;13:105–8.
- Fouchier RA, Schneeburger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci U S A. 2004;101:1356–61.
- Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet. 2004;363:587–93.
- Food and Agriculture Organization. AIDE News: AI Bulletin. Update on the avian influenza situation (as of 12/05/2005). Issue no. 30. [cited 2005 Oct 21]. Available from http://www.fao.org/ag/againfo/subjects/documents/ai/AVIbull030.pdf
- Fauci AS. Race against time. Nature. 2005;435:423–4.
- National Institutes for Allergy and Infectious Diseases. Focus on the flu. 2005 Jun 21 [cited 2005 Oct 21]. Available from http://www2.niaid.nih.gov/Newsroom/FocusOn/Flu04/#resources
- Webby RJ, Perez DR, Coleman JS, Guan Y, Knight JH, Govorkova EA, Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet. 2004;363:1099–103.
- Clements ML, Betts RF, Murphy BR. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection. Lancet. 1984;1:705–8.
- La Montagne JR, Fauci AS. Intradermal influenza vaccination: can less be more? N Engl J Med. 2004;351:2330–2.
- Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, van Hoecke C, Serum antibody responses after intradermal vaccination against influenza. N Engl J Med. 2004;351:2286–94.
- Kenney RT, Frech SA, Muenz LR, Villar CP, Glenn GM. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med. 2004;351:2295–301.
- Ward P, Small I, Smith J, Suter P, Dutkowski R. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother. 2005;55(Suppl 1):i5–21.
- National Center for Biotechnology Information. Influenza virus resource. 2005 Jun 23 [cited 2005 Oct 31]. Available from http://www.ncbi.nlm.nih.gov/genomes/FLU/FLU.html
- Sloan FA, Berman S, Rosenbaum S, Chalk RA, Giffin RB. The fragility of the U.S. vaccine supply. N Engl J Med. 2004;351:2443–7.
- Poland GA, Marcuse EK. Vaccine availability in the US: problems and solutions. Nat Immunol. 2004;5:1195–8.
- Muller MP, McGeer A, Straus SE, Hawryluck L, Gold WL. Clinical trials and novel pathogens: lessons learned from SARS. Emerg Infect Dis. 2004;10:389–94.
- Finlay BB, See RH, Brunham RC. Rapid response research to emerging infectious diseases. Nat Rev Microbiol. 2004;2:602–7.
- National Institute of Allergy and Infectious Diseases. First US SARS vaccine trial opens at NIH. 2004 Dec 13 [cited 2005 Oct 21]. Available from http://www2.niaid.nih.gov/newsroom/releases/sarstrial.htm
1This article is dedicated to the memory of John La Montagne, who died suddenly and unexpectedly in November 2004. Dr. La Montagne was the deputy director of NIAID and a world leader in the fields of influenza and emerging infectious diseases. He is sorely missed by his many colleagues.